当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2013年第16期
编号:13160991
IL—6基因多态性与冠心病发病机制研究(3)
http://www.100md.com 2013年6月5日 张迎军 王悦喜 任保军 阿荣 刘晓宇
第1页

    参见附件。

     [7] Chen Y,Huang H,Liu S,et al. IL-16 rs11556218 gene polymorphismis associated with coronary artery disease in the Chinese Han population [J]. Clin Biochem,2011,44(13):1041-1044.

    [8] Chiappelli M,Tampieri C,Tumini E,et al. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men [J]. International Journal of Immunogenetics,2005,32(6):349-353.

    [9] Woods A,Brull DJ,Humphries SE,et al. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6 [J]. Eur Heart J,2000,21(19):1574-1583.

    [10] Ikeda U,Ito T,Shimada K. Interleukin-6 and acute coronary syndrome [J]. Clin Cardiol,2001,24(11):701-704.

    [11] Soga Y,Nishimura F,Ohyama H,et al. Tumor necrosis factor-alpha gene (TNF-alpha)-1031/-863,-857 single-nucleotide polymorphisms (SN Ps) are associated with severe adult periodontitis in Japanese [J]. J Clin Periodontol,2003,30(6):524-531.

    [12] Rauramaa R,Visnen SB,Luong LA,et al. Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis [J]. Arterioscler Thromb Vasc Biol,2000,20(12):2657-2662.

    [13] Nauck M,Winkelmann BR,Hoffmann MM,et al. The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6,coronary artery disease, and myocardial infarction [J]. J Mol Med(Berl),2002,80(8):507-513.

    [14] 熊娟,何卫,蒋红梅,等.冠心病冠状动脉病变程度与临床生化指标相关性研究[J].中国医药导刊,2011,13(12):2034-2035.

    [15] 陈玉宇.C反应蛋白与冠心病临床研究[J].中国医药导刊,2011,13(12):2062-2064.

    [16] 黄名超,欧琼英.银杏达莫注射液治疗冠心病不稳定型心绞痛疗效观察[J].中国医药导刊,2011,13(12):2116-2118.

    (收稿日期:2013-01-29 本文编辑:卫 轲)

您现在查看是摘要介绍页,详见PDF附件